Skip to main content

Table 2 Clinicopathological factors in the NACT + IDS and PDS groups of patients grouped according to the New Scoring System

From: Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer

Clinicopathological factors Groups with score < 5 Groups with score ≥ 5
NACT + IDS PDS p NACT + IDS PDS p
Age (y) (53.16 ± 9.40) (53.64 ± 10.79) 0.818 (52.94 ± 10.16) (55.77 ± 10.39) 0.176
Stage
 III 38 40 0.343 40 39 0.876
 IV 11 7 10 9
Histology
 Serous 42 41 0.970 44 41 0.819
 Mucous 6 5 5 5
 Endometrioid 1 1 1 2
Grade
 G1 15 19 0.598 16 19 0.448
 G2 4 3 3 5
 G3 30 25 31 24
  1. NACT + IDS neoadjuvant chemotherapy and interval debulking surgery, PDS primary debulking surgery